EPA, FDA, USDA Develop Regulatory Plan for Biotechnology
By Stephen Nakrosis
The U.S. Food and Drug Administration said Wednesday it worked jointly with the Environmental Protection Agency and the Department of Agriculture to develop a regulatory plan for products on biotechnology.
The plan, which came in response to an executive order from President Joe Biden, updates, streamlines and clarifies regulations and oversight mechanisms, the FDA said.
The agencies focused on five areas: modified plants; modified animals; modified microorganisms; human drugs, biologics and medical devices; and cross-cutting issues, and worked with developers and stakeholders, to collaboratively develop the plan, according to the FDA.
The plan includes processes and timelines to implement regulatory reform and identify potential needs for new guidance or regulations, the FDA said, adding that it supports a whole-of-government approach to the regulation of biotechnology products.
The agencies intend to clarify and streamline regulatory oversight for genetically engineered plants, animals and microorganisms, as well as to undertake a pilot project focused on modified microbes to explore developing a web-based tool to informs developers about which agency may regulate a given product category, among other projects.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
May 08, 2024 16:10 ET (20:10 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing